Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New lens implant aims to sharpen vision after cataracts in prior LASIK patients

NCT ID NCT06555289

Symptom relief Sponsor: Juliette Eye Institute Research Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well a specific lens implant (Clareon PanOptix Pro) works during cataract surgery for people who previously had LASIK or PRK to correct nearsightedness. About 40 adults aged 45 and older will receive the implant in both eyes and be followed for 3 months. The goal is to see if the lens improves vision at far, middle, and close distances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Eligible test subjects will be those with age-related cataracts and prior myopic refractive surgery.

Ages

45 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (45 years or older) who have confirmed age-related cataracts and are eligible for bilateral cataract surgery. * Prior binocular myopic photorefractive keratectomy (PRK) or myopic LASIK. * Patients who have regular corneal astigmatism less than or equal to 0.6 D and are candidates for the PanOptix Pro spherical IOL. * Patients who have regular corneal astigmatism and are candidates for PanOptix Pro toric IOL T3 * Postoperative visual potential of monocular 20/25 or better, in the surgeon's judgement. Exclusion Criteria: * Any ocular comorbidity that might hamper postoperative visual acuity: * Corneal abnormality including corneal dystrophy, irregularity, and degeneration. * Moderate or severe dry eyes that can't be relieved after treatment. * History of or current anterior and posterior inflammation of any etiology. * Retinal pathology such as AMD, diabetic retinopathy, vein occlusion, etc. * Glaucoma of any kind. * Pregnancy or lactation. * Any ocular surgery other than corneal myopic refractive surgery (LASIK and PRK). * Patients with physical or intellectual disability (e.g. Down's Syndrome, Parkinson's Disease, unable to fixate) * Apple Kappa/chord mu ≥ 0.6. * Higher order corneal aberrations at pupil diameter of 4mm: \> 0.6 total RMS, \> 0.3 coma, \> 0.3 trefoil (to exclude irregular corneas) * Any patient requiring a limbal relaxing incision. The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cataract are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cataract

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Juliette Eye Institute Research Center

    RECRUITING

    Albuquerque, New Mexico, 87113, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.